
Cellexus will present their latest research during Targeting Phage Therapy 2023
Adam Ostrowski, Cellexus, United Kingdom will present a short oral talk entitled “Implementing GMP Manufacturing for Phage Therapy” during Targeting Phage Therapy 2023 on June 1-2 in Paris. The CellMaker single use, airlift bioreactor is an ideal fermentation system for phage production in a GMP environment. The patented airlift technology provides excellent mixing and aeration…